Fig. 6From: The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic micePathological results of the mouse liver, lungs, kidneys and BM after transplantation. No tumours were observed in the liver, lungs, kidneys or BM of mice in any group at 10 weeks after transplantation. Scale bar, 100 μmBack to article page